JDDonline.com

Emervel: Full-Face Rejuvenation With a Range of Customized Hyaluronic Acid Fillers This supplement to the Journal of Drugs in Dermatology discusses a new range of hyaluronic acid fillers suited for various indications. The authors highlight the key physical properties of this new range of fillers and present results of a multi-center, comprehensive trial in which up to eight indications could be treated simultaneously (including nasolabial folds, marionette lines, periorbital lines, upper lip lines, cheek folds, tear-troughs, lips and cheeks) using this filler range.  

As the population of the world shifts to include more patients of skin of color than ever before, learning how to appropriately treat this patient population has become increasingly more important to practicing clinicians. Patients of skin of color face unique challenges when it comes to procedures such as laser hair removal and treatment of conditions such as Pseudofolliculitis Barbae. This body of work seeks to provide dermatologists with unique clinical pearls discussing the use of safe treatment modalities in the skin of color population. From the use of lasers to the effective use of fillers and injectables, this body of work is filled with expert advice for optimizing treatment outcomes and increasing patient satisfaction. Via these clinical pearls, dermatologists can better meet the needs of a changing patient population as well as expand their knowledge base.  

This supplement to the Journal of Drugs in Dermatology seeks to advance our knowledge of the structure and function of the stratum corneum. Previously considered a "static" or unremarkable barrier, it has now attained new clinical importance in regards to its role in conditions such as atopic dermatitis and other cutaneous abnormalities. Dr. Brian Berman provides an insightful introduction to articles by Dr. James Q. Del Rosso and Dr. Jacquelyn Levin, as well as by Dr. Paul C. Contard, that discuss the role and relevance of the stratum corneum in today's dermatologic world.  

The dermatologic application of natural ingredients in skin care has evolved significantly in the past two decades. Research into the mechanisms and biochemistry of natural ingredients has lead to the development of new technologies and formulations that provide a therapeutic benefit in the treatment of dermatologic conditions and the aging process.
Providing optimal patient outcomes continues to be a challenge in the treatment and management of dermatologic conditions. Most physicians and patients are interested in doing everything possible to optimize the treatment of their skin disease. This is especially important in treating patients with chronic disorders such as eczema, acne, psoriasis, rosacea, photodamage and the negative effects of aging. Physicians and patients often explore the therapeutic benefits of natural ingredients as alternative or complementary treatments to conventional methods. It is important that dermatologists remain up-to-date on the research and new advances in skin care products with natural ingredients.

This is a CME supplement; visit the JDD Medical Education Library to participate in this activity and earn 1 category 1 CME Credit.
 

Despite the fact that acne is among the most common conditions treated by dermatologists, challenges in managing acne patients are encountered on a daily basis. The articles in this supplement help to address some of those challenges, namely choice of appropriate topical formulations, management of acne in patients with skin of color and appropriate use of oral antibiotics in an age of emerging antibiotic-resistant bacteria.

This is a CME supplement; visit the JDD Medical Education Library to participate in this activity and earn 1 category 1 CME Credit.
 

Scalp Psoriasis, How and When to Use Biologics in Psoriasis, Enhancing the Eyes: Use of Minimally Invasive Techniques for Periorbital Rejuvenation, and Facial Shaping: Beyond Lines and Folds With Fillers  

Acne vulgaris can cause both physical and emotional scarring. Effective treatment requires an understanding of acne pathogenesis and the key elements of keratinocyte differentiation and comedone formation, sebum production, colonization with Propionibacterium acnes (P. acnes) and subsequent inflammation. Addressing issues of compliance is critical for good outcomes, and newer combination therapies help improve adherence to daily therapy.  

Natural ingredients have been used traditionally for millennia and their application in topical creams, lotions and preparations within the traditional medicines and healing traditions of many cultures has been observed. Over the last 20 years, clinical and laboratory studies have identified the benefits of an array of natural ingredients for skin care. Consequently, a number of these ingredients and compounds are today being developed, used or considered not only for anti-aging effects, but also for use in dermatologic disorders. Certain ingredients, such as colloidal oatmeal and aloe vera, have been identified as beneficial in the treatment of psoriasis and atopic dermatitis, respectively, due to their anti-inflammatory properties. For combating acne and rosacea, green tea, niacinamide and feverfew are considered efficacious. As to hyperpigmentation and antioxidative capabilities, licorice, green tea, arbutin, soy, acai berry, turmeric and pomegranate are among those plants and compounds found to be most beneficial. Additional research is needed to determine to confirm and elucidate the benefits of these ingredients in the prevention and management of skin disease.  

This supplement to the Journal of Drugs in Dermatology is supported by Graceway Pharmaceuticals, LLC, Ortho Dermatologics, Inc., Osyris and The Procter & Gamble Company  

This supplement to the Journal of Drugs in Dermatology is supported by an educational grant from Medicis Pharmaceutical Corporation.  

This supplement to the Journal of Drugs in Dermatology is jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and Signature Business Solution, LLC.This activity is supported by an independent educational grant from Medicis Pharmaceutical Corporation.  

This supplement to the Journal of Drugs in Dermatology is supported by Alma Lasers, Candela Corporation, Cynosure, and Syneron.  

This activity was made possible through an educational grant provided by Sanofi-Aventis

 

This activity is supported by an educational donation provided by Astellas Pharma US Inc. and Amgen and Wyeth Pharmaceuticals.

 

Funding for the supplement provided by Galderma Laboratories, L.P..

 

This supplement to the Journal of Drugs in Dermatology is sponsored by P&G Beauty & Grooming.

 

This supplement to the Journal of Drugs in Dermatology was supported by a medical education grant from Johnson & Johnson.

 

This supplement to the Journal of Drugs in Dermatology was made possible through an educational grant provided by SkinMedica.  

This supplement to the Journal of Drugs in Dermatology was made possible through an educational grant provided by Genentech, Inc.  

This supplement to the Journal of Drugs in Dermatology was supported by a medical education grant from Cosmetic Bootcamp.

Cosmetic Bootcamp would like to thank the sponsors of the JDD April 2009 supplement issue, "Update on Injectable Facial Rejuvenation," for their dedication and ongoing commitment to core physician education and optimal patient outcomes.

Thank You
         

This supplement to the Journal of Drugs in Dermatology was supported by an independent educational grant from Ortho Dermatologics.  

This supplement to the Journal of Drugs in Dermatology was supported by a medical education grant from Johnson & Johnson.  

This supplement to the Journal of Drugs in Dermatology was supported by a medical education grant from Johnson & Johnson.  

This supplement to the Journal of Drugs in Dermatology was supported by an independent educational grant from Galderma.  

This supplement to the Journal of Drugs in Dermatology was supported by a medical educational grant from OrthoNeutrogena.  

This supplement to the Journal of Drugs in Dermatology was supported by an independent educational grant from Obagi Medical.  

This supplement to the Journal of Drugs in Dermatology was supported by a medical education grant from Graceway Pharmaceauticals.  

This supplement to the Journal of Drugs in Dermatology was supported by Dior  

This supplement to the Journal of Drugs in Dermatology was supported by Dermik.  

This supplement to the Journal of Drugs in Dermatology was supported by Dusa Pharmacueticals.  

This supplement to the Journal of Drugs in Dermatology was supported by Medicis Pharmaceutical Corp..  

This supplement to the Journal of Drugs in Dermatology was supported by Dermik Laboratories.  

This supplement to the Journal of Drugs in Dermatology was supported by Dermik Laboratories.